A Single-blind, Randomized, Active-controlled, Multi-center and Phase IV Study to Evaluate the Small Airway Parameters of Fluticasone/Formoterol (Flutiform) Compared to Fluticasone/Salmeterol in Asthma Patients
Phase of Trial: Phase IV
Latest Information Update: 16 May 2017
At a glance
- Drugs Formoterol/fluticasone propionate (Primary) ; Salmeterol/fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Acronyms RECONFFIRM
- Sponsors Mundipharma International
- 11 May 2017 Status changed from recruiting to completed.
- 05 Jan 2017 Planned End Date changed from 1 Mar 2017 to 1 Jun 2017.
- 05 Jan 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Mar 2017.